← Leaderboards
Joseph John Mattapallil
Henry M. Jackson Fdn For The Adv Mil/Med
$4,666,023
Attributed
$4,666,023
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $987K · FY2007–25$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,666,023 · 6
By mechanism
R01$2,381,252 · 1
R21$1,310,798 · 3
R56$703,973 · 1
K22$270,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionCellsPlayCd4 Positive T LymphocytesKineticsCd8b1 GeneT-LymphocyteResponseViralMacaca MulattaVirus DiseasesImmune ResponseMediatingT-Lymphocyte SubsetsMucous MembraneInsightTissuesBasePreventPublic Health RelevancePathogenImmunologic Deficiency SyndromesAnimalsCell Count
Grant awards (12)
Delineating the kinetics of spinal pathology in the EV-D68 infected ferret model$217,976
R21 · FY2025 · AI · contact PI
Development of the ferret model for EV-D68 infection$152,496
R21 · FY2021 · AI · contact PI
Development of the ferret model for EV-D68 infection$266,869
R21 · FY2020 · AI · contact PI
ADCC and functional cure in SIV infection$703,973
R56 · FY2016 · AI · contact PI
Mucosal immunity and rectal challenge$541,106
R01 · FY2011 · DE · contact PI
Mucosal immunity and rectal challenge$853,120
R01 · FY2010 · DE · contact PI
Mucosal immunity and rectal challenge$987,026
R01 · FY2009 · DE · contact PI
Mucosal Epithelium and Long-Term Anti-Retroviral Therapy$254,518
R21 · FY2008 · DE · contact PI
Mucosal Epithelium and Long-Term Anti-Retroviral Therapy$113,339
R21 · FY2008 · DE · contact PI
CD4 T cells and anti-viral control in SIV infection$108,000
K22 · FY2008 · AI · contact PI
Mucosal Epithelium and Long-Term Anti-Retroviral Therapy$305,600
R21 · FY2007 · DE · contact PI
CD4 T cells and anti-viral control in SIV infection$162,000
K22 · FY2007 · AI · contact PI